Stem Cell Company Presents Findings Of Adult Stem Cell Safety And Feasibility Study


Share to Facebook Share to Twitter Stumble It Email This More...

DaVinci Biosciences LLC, of Costa Mesa, CA, announced today the presentation of their safety and feasibility study demonstrating the administration of autologous bone marrow derived stem cells for the treatment of acute and chronic spinal cord injury at Neuroscience 2009, Society for Neuroscience’s 39th Annual Meeting, to be held at McCormick Convention Center in Chicago, IL. Rafael Gonzalez, Ph.D., Director of Research and Development for DaVinci Biosciences LLC will present the work during the conference on October 20, 2009 and be available to answer questions regarding the study, following his presentation.

“We are excited to share the findings of this study in such a public forum. This study successfully demonstrates not only the safety and feasibility of using autologous adult stem cells for treating spinal cord injuries, but also that the clinical procedure for delivering these cells is safe as well,” said Dr. Gonzalez.

The abstract highlights data from 8 patients that underwent the treatment which used stem cells harvested from the patients’ own bone marrow to side step any immune rejection response, and features the documented evaluations from a 2 year post surgical follow up period. Furthermore, it illustrates new data obtained from 46 patients that participated in the study using stem cells harvested from the patients’ own bone marrow. Magnetic resonance imaging data of the spinal cord, obtained from those who were treated, shows morphological changes within the damaged areas. In addition, this study documents the improved function of bladder control, ASIA motor scoring and Barthel scoring.

“Although this study was successful, we will build upon the results that we have achieved and the methods we have developed to progress into a larger clinical program. Responsibly, but timely developing ways to improve the quality of life for those affected with injuries or diseases, such as spinal cord injury, is the core of our mission and we are optimistic about the opportunity of conducting future studies in the US,” said Dr. Gonzalez.

from http://www.dvbiosciences.com/

Reblog this post [with Zemanta]

Maybe you can find something interesting in the following sponsored links:


Share to Facebook Share to Twitter Stumble It Email This More...
Related pages on the web
  • Hey Monday Say 'The Show Must Go On' 'Quitting a band you're not happy being a part of can't really wait,' HM's Cassadee Pope says of departed bassist Jersey Moriarty.By James Montgomery Hey Monday Photo: MTV News Last week, Hey Monday sent their fanbase into a panic when...
  • Male Bass in Numerous US Rivers Seem to Have Been Feminized According to Study Government scientists are figuring that one out of every five black bass in the American river basins, despite being male, have egg cells that are growing inside of their typical sex organs, and this is a sign of just how...
  • Judge stops federal funding of embryonic stem cell research [/caption] Washington -- A U.S. district judge granted a preliminary injunction Monday to stop federal funding of embryonic stem cell research that he said destroys embryos, ruling it went against the will of Congress. The ruling by Judge Royce C....
  • The Power of The Placebo Effect - How Can 35-45% of People Cure Themselves? How Powerful is the Placebo Effect? One of the most confounding things for modern, medical science to explain is called the ‘placebo effect’.  A placebo is a sugar pill administered to a test patient who believes it’s an actual drug. ...
  • How Much...errr, Little Exercise Do You Need? Exercise is like a magic pill. It does so many good things for your body, mind, and spirit. However, we often come across the question of, “How much exercise do I really need?” Unfortunately, the answer isn’t so clear cut....
Blog Traffic Exchange Related articles on this site

0 Responses to “Stem Cell Company Presents Findings Of Adult Stem Cell Safety And Feasibility Study”


  1. No Comments

Leave a Reply